Skip to main content

Anatomic Pathology Market to Surpass 65.54 Billion by 2030 Drives Due to Widespread Utilization of Clinical Biomarkers

SkyQuest projects that the anatomic pathology market will attain a value of USD 65.54 billion by 2030, with a CAGR of 7.3% over the forecast period (2023-2030). The anatomic pathology market is witnessing growth driven by the increasing reliance on pathology tests and procedures based on biomarkers. Biomarkers play a crucial role in the investigation of common malignancies and the understanding of tumorigenesis. In addition, these tests enable pathologists to detect specific molecular and genetic alterations, facilitating accurate diagnoses, treatment decisions, and predictive assessments.

Westford,USA, Aug. 15, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the global anatomic pathology market is expected to experience significant growth over the forecast period, primarily owing to the widespread utilization of clinical biomarkers in determining the pathogenesis of diseases at a molecular level. This advancement empowers pathologists to gain deeper insights into the underlying mechanisms of diseases and make more informed clinical decisions.

Browse in-depth TOC on the “Anatomic Pathology Market”

  • Pages – 265
  • Tables – 89
  • Figures – 76

Anatomic pathology is a medical specialty that examines and diagnoses diseases by analyzing tissues and organs at various levels, including microscopic, macroscopic, immunologic, biochemical, and molecular levels. This field is crucial in identifying and understanding the nature of diseases through comprehensive examination techniques in the anatomic pathology market. Anatomic pathology typically requires the expertise of a physician who has received specialized training in pathological diagnosis.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/anatomic-pathology-market

Prominent Players in Anatomic Pathology Market

  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Sakura Finetek Japan Co., Ltd.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Siemens AG
  • Cell Signaling Technology, Inc.
  • PerkinElmer Inc.
  • Enzo Life Sciences, Inc.
  • Abcam plc
  • Epitomics, Inc.
  • Biocare Medical, LLC
  • Ventana Medical Systems, Inc.
  • Leica Biosystems Nussloch GmbH

Hospital Segment is Expected to Dominate the Market Due to the High Hospitalization Rate among Patients

Hospital segment emerged as the dominant anatomic pathology market share holder in the field of anatomic pathology. This segment is also expected to witness a robust growth rate throughout the forecast period and maintain its position of dominance. The high hospitalization rate of patients across different medical conditions, coupled with a significant number of frequent readmissions, is a key driving factor for the growth of this segment globally.

The markets inNorth America have emerged as the leading region in terms of revenue share in the anatomic pathology market, primarily owing to several key factors. One significant factor is the presence of major players in the industry, who have contributed to the development and advancement of anatomic pathology technologies. Additionally, the region benefits from supportive government initiatives to enhance the training of pathological programs, ensuring a skilled workforce.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/anatomic-pathology-market

Disease Diagnosis Segment is Expected to Grow the Market Due to the Wide-Ranging Applications of Anatomic Pathology

Disease diagnosis segment dominated the anatomic pathology market in 2022, holding the largest market share. This can be attributed to the wide-ranging applications of anatomic pathology in disease diagnosis and the escalating prevalence of various chronic disorders such as cancer. Accurately diagnosing diseases is crucial for effective treatment and management, driving the demand for anatomic pathology services.

Regional markets in the Asia Pacific region are projected to witness substantial growth in the anatomic pathology market during the forecast period. This can be attributed to multiple factors, including the rising senior population and the increasing incidence of chronic diseases across the region.

A comprehensive analysis of the major players in the anatomic pathology market has been recently conducted in a report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavours to develop innovative solutions to cater to the growing demand.

Key Developments in Anatomic Pathology Market

  • Roche, a renowned healthcare company, recently introduced the VENTANA DP 600 slide scanner, a cutting-edge digital pathology solution. This advanced technology has significantly contributed to precision diagnostics, enhancing patient care. The VENTANA DP 600 slide scanner enables pathologists to digitize and analyze pathology slides highly and efficiently, facilitating accurate diagnoses and personalized treatment decisions.
  • EmeritusDX, a rapidly growing cancer diagnostics and information company, made a strategic acquisition. They acquired Freedom Pathology Partners, a reputable provider of Anatomic Pathology, Fluorescence in situ Hybridization (FISH), and Molecular testing services. This acquisition aimed to expand EmeritusDX’s national presence and strengthen its capabilities in delivering comprehensive diagnostic solutions.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/anatomic-pathology-market

Key Questions Answered in Anatomic Pathology Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.                        
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Health Care Fraud Analytics Market

Global Medical Vacuum Systems Market

Global Benign Prostatic Hyperplasia Treatment Market

Global Dental Laboratories Market

Global Portable Oxygen Concentrators Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.